Clinical Trials Directory

Trials / Terminated

TerminatedNCT01185691

Investigating the Role of Impella 2.5 System in Acutely Decompensated Chronic Heart Failure Patients

RELIEF I: Investigating the Role of IMPELLA 2.5 System In Acutely Decompensated Chronic Heart Failure Patients. A Prospective, Single Center Feasibility Study

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
1 (actual)
Sponsor
Abiomed Inc. · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to assess safety and feasibility of IMPELLA 2.5 in Acute Decompensated Heart Failure patients.

Conditions

Interventions

TypeNameDescription
DEVICEImpella 2.5Impella 2.5 implant in patients with acute decompensated heart failure

Timeline

Start date
2010-07-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2010-08-20
Last updated
2013-05-03

Source: ClinicalTrials.gov record NCT01185691. Inclusion in this directory is not an endorsement.

Investigating the Role of Impella 2.5 System in Acutely Decompensated Chronic Heart Failure Patients (NCT01185691) · Clinical Trials Directory